Affordable cancer drug gets lab test against tough blood cancers

NCT ID NCT04234022

Recruiting now Knowledge-focused Sponsor: The Royal Wolverhampton Hospitals NHS Trust Source: ClinicalTrials.gov ↗

Summary

This study aims to see if a drug called Imuthiol (Zn-DDC), which has been safe in past trials, can kill cancer cells from patients with multiple myeloma or acute leukemia. Researchers will test the drug alone and combined with other medications on cells in a lab, using bone marrow samples donated by 70 patients. The goal is to gather evidence to see if this affordable drug should move into future treatment trials.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

The Royal Wolverhampton NHS Trust
RECRUITING

Wolverhampton, WV10 0QP, United Kingdom

Contact Email: •••••@•••••

Contact Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA